“According to the Business Roundtable Health Care Value Comparability Study, a new measure of the “value” (cost and performance) of the U.S. health care system relative to our competitors’ systems on a weighted scale, the workers and employers of the United States face a 23 percent “value gap” relative to five leading economic competitors – Canada, Japan, Germany, the United Kingdom and France (the “G-5 group”) – and a 46 percent “value gap” compared with emerging competitors Brazil, India and China (“the BIC group”). What does this “value gap“ mean for our ability to compete in the international marketplace?”